1. Home
  2. GDRX vs PCRX Comparison

GDRX vs PCRX Comparison

Compare GDRX & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$2.51

Market Cap

883.9M

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.46

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDRX
PCRX
Founded
2011
2006
Country
United States
United States
Employees
697
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
883.9M
1.0B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
GDRX
PCRX
Price
$2.51
$22.46
Analyst Decision
Buy
Strong Buy
Analyst Count
9
4
Target Price
$3.66
$30.25
AVG Volume (30 Days)
1.6M
533.8K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
107.44
EPS
N/A
0.07
Revenue
$796,853,000.00
$541,533,000.00
Revenue This Year
N/A
$6.78
Revenue Next Year
$5.38
$8.54
P/E Ratio
$28.94
$324.86
Revenue Growth
0.57
26.04
52 Week Low
$1.77
$18.80
52 Week High
$5.61
$27.64

Technical Indicators

Market Signals
Indicator
GDRX
PCRX
Relative Strength Index (RSI) 51.96 40.41
Support Level $2.15 $21.80
Resistance Level $2.95 $24.20
Average True Range (ATR) 0.17 1.23
MACD -0.02 -0.25
Stochastic Oscillator 33.56 5.58

Price Performance

Historical Comparison
GDRX
PCRX

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: